Immunic Stock Price - IMUX

1.01 (11.46%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.17 1.97% 8.81 8.67 9.19 8.67 8.64 00:00:06
Bid Price Ask Price Spread Spread % News
7.20 11.00 3.80 34.55% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
219 11,510 $ 8.91 $ 102,559 18,459 6.20 - 22.6626
Last Trade Time Type Quantity Stock Price Currency
17:38:38 1 $ 9.82 USD

Immunic Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 89.13M 10.12M $ -41.48M -39.20 - 9.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 3.00 3.30%

more financials information »

Immunic News

Loading Messages....

Latest IMUX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.689.208.118.827,6760.131.5%
1 Month9.229.508.038.7817,329-0.41-4.45%
3 Months7.009.996.728.5433,6621.8125.86%
6 Months13.5017.24246.2010.0829,890-4.69-34.74%
1 Year22.0022.66266.2013.0475,132-13.19-59.95%
3 Years22.0022.66266.2013.0475,132-13.19-59.95%
5 Years22.0022.66266.2013.0475,132-13.19-59.95%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.